Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5
datasets available to search
ShareScore release 0.9.0
Dataset results
5 results for “modified Rankin Scale”
Data from: Three-month modified Rankin Scale as a determinant of five-year cumulative costs after ischemic stroke: an analysis of 11,136 patients in Korea
Objective: Stroke is a devastating and costly disease; however, there is a paucity of information on long-term costs and on how they differ according to 3-month modified Rankin scale (mRS), which is a primary outcome variable in acute stroke intervention trials. Methods: We analyzed a prospective multicenter stroke registry (Clinical Research Collaboration for Stroke in Korea) database through linkage with claims data from the National Health Insurance Service with follow up to December 2016. Healthcare expenditures were converted into daily cost individually, and annual and cumulative costs up to 5 years were estimated and compared according to the 3-month mRS. Results: Between January 2011 and November 2013, 11,136 patients were enrolled in the study. The mean age was 68 years, and 58% were men. The median follow-up period was 3.9 years (range 0–5 years). Mean cumulative cost over 5 years was $117,576 US dollar (USD); the cost in the first year after stroke was the highest ($38,152 USD), which increased markedly from the cost a year before stroke ($8,718 USD). The mean 5-year cumulative costs differed significantly according to the 3-month mRS (P<.001); the costs for a 3-month mRS score of 0 or 5 were $53,578 USD and $257,486 USD, respectively. Three-month mRS was an independent determinant of long-term costs after stroke. Conclusions: We shows that 3-month mRS plays an important role in the prediction of long-term costs after stroke. Such estimates relating to 3-month mRS categories may be valuable when undertaking health economic evaluations related to stroke care.
Data from: Three-month modified Rankin Scale as a determinant of five-year cumulative costs after ischemic stroke: an analysis of 11,136 patients in Korea
Open the record for dataset details and reuse information.
Data from: Ordinal vs dichotomous analyses of modified Rankin Scale and 5-year outcome and cost of stroke
Objective – To compare how three common representations (ordinal versus dichotomized as 0-1/2-6 or 0-2/3-6) of the modified Rankin Scale (mRS) – a commonly-used trial outcome measure – relate to long-term outcomes, and quantify trial ineligibility rates based on pre-morbid mRS. Methods – In consecutive ischaemic stroke patients in a population-based, prospective cohort study (Oxford Vascular Study; 2002-2014), we related 3-month mRS to 1-year and 5-year disability and death (logistic regressions), and health/social-care costs (generalized linear model), adjusted for age/sex, and compared goodness-of-fit values (c-statistic, Mean Absolute Error [MAE]). We also calculated the proportion of patients in whom pre-morbid mRS >1 or >2 would result in exclusion from trials using dichotomous analysis. Results – Among 1,607 patients, the ordinal mRS was more strongly related to 5-year mortality than both the 0-1/2-6 and 0-2/3-6 dichotomies (all p<0.0001). Results were similar for 5-year disability, and 5-year care costs were also best captured by the ordinal model (ΔMAE versus age/sex: -3,059 for ordinal, -2,805 for 0-2/3-6, -1,647 for 0-1/2-6). 244 (17.1%) 3-month survivors had pre-morbid mRS>2 and 434 (30.5%) had mRS>1; both proportions increased with female sex, socio-economic deprivation, and age (all p<0.0001). Conclusions – The ordinal form of the 3-month mRS relates better to long-term outcomes and costs in survivors of ischaemic stroke than either dichotomy. This finding favours using ordinal approaches in trials analysing the mRS. Exclusion of patients with higher pre-morbid disability by use of dichotomous primary outcomes will also result in unrepresentative samples.
Data from: Ordinal vs dichotomous analyses of modified Rankin Scale and 5-year outcome and cost of stroke
Open the record for dataset details and reuse information.
Effect of E-learning Training on National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) Assessment
ClinicalTrials.gov study NCT07318376. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.